Charleston, SOUTH%20CAROLINA1 Active Studies

Neuroendocrine Tumors Clinical Trials in Charleston, SOUTH%20CAROLINA

Find 1 actively recruiting neuroendocrine tumors clinical trials in Charleston, SOUTH%20CAROLINA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
30
Enrolling

Recruiting Neuroendocrine Tumors Studies in Charleston

About Neuroendocrine Tumors Clinical Trials in Charleston

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 1 neuroendocrine tumors clinical trials recruiting participants in Charleston, SOUTH%20CAROLINA. These studies are seeking a combined 30 participants. Research is being sponsored by Quoin Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Charleston — FAQ

Are there neuroendocrine tumors clinical trials in Charleston?

Yes, there are 1 neuroendocrine tumors clinical trials currently recruiting in Charleston, SOUTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charleston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.

Are clinical trials in Charleston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 1 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated March 2, 2026 from ClinicalTrials.gov